Jonas A. Castelijns

Axonal loss in multiple sclerosis lesions: Magnetic resonance imaging insights into substrates of disability

J.H.T.M. van Waesberghe, W. Kamphorst, Corline J.A. De Groot et al. · Annals of Neurology · 1999 · 730 citations · Full text

Medicine, Neurology, Radiology +17

Performance of Immuno–Positron Emission Tomography with Zirconium-89-Labeled Chimeric Monoclonal Antibody U36 in the Detection of Lymph Node Metastases in Head and Neck Cancer Patients

Pontus K.E. Börjesson, Yvonne W. S. Jauw, Ronald Boellaard et al. · Clinical Cancer Research · 2006 · 238 citations · Full text

Medicine, Nuclear Medicine, Oncology +16

Guidelines for imaging retinoblastoma: imaging principles and MRI standardization

Pim de Graaf, Sophia Göricke, Firazia Rodjan et al. · Pediatric Radiology · 2011 · 226 citations · Full text

Medicine, Ophthalmology, Radiology +17

Neuronal damage in T1-hypointense multiple sclerosis lesions demonstrated in vivo using proton magnetic resonance spectroscopy

Marianne A.A. van Walderveen, Frederik Barkhof, Petra J. W. Pouwels et al. · Annals of Neurology · 1999 · 209 citations

Medicine, Neurology, Neuroscience +17

Radiation Dosimetry of ⁸⁹Zr-Labeled Chimeric Monoclonal Antibody U36 as Used for Immuno-PET in Head and Neck Cancer Patients

Pontus K.E. Börjesson, Yvonne W. S. Jauw, Remco de Bree et al. · Journal of Nuclear Medicine · 2009 · 170 citations · Full text

Medicine, Oncology, Radiology +15